Auf dieser Seite
01DVA Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
25Handelssignale
26Meine Kennzahlen
DVA DaVita Inc. Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 6, 2026 10-K/10-Q Aug 4, 2026
$180,40
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$101,0052-Wochen-Tief
$247,4952-Wochen-Hoch
Marktkapitalisierung (MRQ)
$11.54B
P/E (TTM)
14.8
EPS (TTM)
$12.15
Umsatz (TTM)
$14.01B
Ihre Abzeichen
52W-Spanne
$101–$247
Analystenbewertung
BUY
Kursziel
$220
P/E
14.8
ROE
-149.4%
Nettogewinnmarge
6.0%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
DVA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$180.40
Marktkapitalisierung (MRQ)
$11.54B
P/E (TTM)
14.8
EPS (TTM)
$12.15
Umsatz (TTM)
$14.01B
Dividendenrendite
0.00%
ROE (TTM)
-149.4%
52W-Spanne
$101–$247
DVA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 9. September 2013 | 2-for-1 | Vorwärts |
| 16. Juni 2004 | 3-for-2 | Vorwärts |
| 21. Oktober 1997 | 5-for-3 | Vorwärts |
Über DaVita Inc. Common Stock Unternehmensübersicht von Wikipedia
DaVita Inc. ist ein weltweit tätiger US-amerikanischer Anbieter von Dialysedienstleistungen für Patienten mit chronischem und akutem Nierenversagen.
Unternehmensgeschichte
Das Unternehmen wurde 1994 als Total Renal Care (TRC) gegründet. CEO war Victor Chaltiel. Chaltiel trat im Juli 1999 nach zwei enttäuschenden Quartalsberichten und einer Reihe von Class Action Suits, unter anderem wegen unzureichender Rechnungslegung (inadequate financial statement disclosures), zurück. Das Unternehmen war dem Konkurs nah und die Marktkapitalisierung lag unter 200 Millionen USD. Im Oktober 1999 wurde der Harvard-Absolvent Kent Thiry neuer CEO. Er strukturierte das Unternehmen grundlegend um und änderte den Namen in DaVita. Thiry nutzte dabei teilweise ungewöhnliche Methoden. So traten er und andere Mitglieder des oberen Managements in Kostümen verkleidet als Die drei Musketiere mit Call and Response von All for one, one for all („Einer für alle, alle für einen“) vor den Mitarbeitern des Unternehmens auf. Das Unternehmen wuchs in den Folgejahren kontinuierlich und hat heute, Stand Dezember 2021, eine Marktkapitalisierung von etwa 11 Milliarden Euro. Mit Wirkung zum 1. Juni 2019 wurde Thiry durch Javier J. Rodriguez als CEO abgelöst.
Zwischen 2012 und 2015 zahlte DaVita in drei Prozessen nahezu 1 Milliarde USD wegen Betrugs des staatlichen Medicare-Systems. Die Zahlungen erfolgten ohne Schuldeingeständnis (does not admit any wrongdoing) des Unternehmens. Aktuell läuft ein Prozess gegen das Unternehmen und den ehemaligen CEO Kent Thiry wegen Wettbewerbsverstößen und Behinderung der Arbeitnehmerfreizügigkeit. Stand Dezember 2021 war das Verfahren noch nicht abgeschlossen.
In den Vereinigten Staaten betreibt DaVita 2.822 ambulante Dialysezentren, außerhalb der Vereinigten Staaten betreibt das Unternehmen 333 ambulante Dialysezentren in 10 Ländern, welche zusammen rund 241.600 Patienten versorgen. (Stand: September 2021) DaVitas größter Konkurrent ist das Unternehmen Fresenius Medical Care (FMC).
DaVita in Deutschland
Seit dem 1. Oktober 2021 ist Tobias Große Wentrup Vorstandsvorsitzender und CEO von DaVita in Deutschland.
In Deutschland hat das Unternehmen mit Stand 16. Dezember 2021 insgesamt 65 Dialysezentren. Folgende Gesellschaften unterhält DaVita in Deutschland:
DaVita Deutschland AG
DaVita Deutschland Beteiligungs GmbH & Co. KG
DaVita Germany GmbH
MVZ DaVita Alzey GmbH
MVZ DaVita Aurich GmbH
MVZ DaVita Bad Aibling GmbH
MVZ DaVita Bad Düben GmbH
MVZ DaVita Dillenburg GmbH
MVZ DaVita Dinkelsbühl GmbH
MVZ DaVita Dormagen GmbH
MVZ DaVita Dresden GmbH
MVZ DaVita Duisburg GmbH
MVZ DaVita Elsterland GmbH
MVZ DaVita Emden GmbH
MVZ DaVita Falkensee GmbH
MVZ DaVita Gera GmbH
MVZ DaVita Markgräflerland GmbH
MVZ DaVita Mönchengladbach GmbH
MVZ DaVita Neuss GmbH
MVZ DaVita Niederrhein GmbH
MVZ DaVita Nierenzentrum Aachen Alsdorf GmbH
MVZ DaVita Nierenzentrum Berlin-Britz GmbH
MVZ DaVita Nierenzentrum Hamm-Ahlen GmbH
MVZ DaVita Prenzlau-Pasewalk GmbH
MVZ DaVita Rhein-Ahr GmbH
MVZ DaVita Rhein-Ruhr GmbH
MVZ DaVita Salzgitter-Seesen GmbH
MVZ DaVita Schwalm-Eder GmbH
MVZ DaVita Süd-Niedersachsen GmbH
MVZ DaVita Viersen GmbH
Verquickung mit der Politik
Während ihrer Zeit als Bundestagsabgeordnete beriet die CDU-Politikern Karin Maag das Unternehmen, wofür sie zwischen 3.500 und 7.000 jährlich erhielt. In dieser Zeit war sie Mitglied des Gesundheitsausschusses. Sie sieht in ihrer Nebentätigkeit aber keinen Interessenkonflikt. Die Organisation Lobbycontrol dagegen schon: „Die DaVita Medical Group könnte einerseits von Maags Insiderwissen profitieren und somit einen Vorteil gegenüber anderen Akteuren in dem Feld haben“, sagte Ulrich Müller von Lobbycontrol. „Außerdem besteht das Risiko, dass Frau Maag bei politischen Entscheidungen nicht unbefangen ist und möglicherweise bewusst oder unbewusst Positionen der DaVita Medical Group stärker berücksichtigt als andere Positionen.“
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealth Care
BrancheHealth Care
Mitarbeiter78.000
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$13.64B2016-12-31 → 2025-12-31
EPS$9.842016-12-31 → 2025-12-31
Freier Cashflow$1.31B2016-12-31 → 2025-12-31
Nettogewinnmarge6.0%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | DVA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 14.85-Jahres-Durchschnitt ≈13.0 | ≈13.0 | 23.4 | Unterbewertet | |
| P/S (TTM) | 0.85-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 1.8 | Unterbewertet | |
| K/B (MRQ) | -15.15-Jahres-Durchschnitt ≈24.1 | ≈24.1 | · | · | |
| Kurs / FCF (TTM) | 7.25-Jahres-Durchschnitt ≈7.2 | ≈7.2 | · | · | |
| Kurs / Cashflow (TTM) | 5.35-Jahres-Durchschnitt ≈4.9 | ≈4.9 | 11.3 | Unterbewertet | |
| Kurs / Materieller Buchwert (MRQ) | -11.6 | · | · | · | |
| PEG Ratio (PEG-Ratio) | ≈1.6 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | DVA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 15.2%5-Jahres-Durchschnitt ≈14.3% | ≈14.3% | 9.2% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 20.2%5-Jahres-Durchschnitt ≈20.1% | ≈20.1% | 12.7% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 10.5%5-Jahres-Durchschnitt ≈10.6% | ≈10.6% | 4.3% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 6.0%5-Jahres-Durchschnitt ≈6.3% | ≈6.3% | 5.1% | Spitzenklasse | |
| ROA (TTM) | 4.8%5-Jahres-Durchschnitt ≈4.6% | ≈4.6% | 3.7% | Spitzenklasse | |
| ROE (TTM) | -149.4%5-Jahres-Durchschnitt ≈24.7% | ≈24.7% | 10.5% | Schwach | |
| ROIC | -245.6%5-Jahres-Durchschnitt ≈325.5% | ≈325.5% | 5.1% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | DVA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.55-Jahres-Durchschnitt ≈1.3 | ≈1.3 | 1.5 | Im Einklang | |
| Quick Ratio (MRQ) | 1.15-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.0 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | DVA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 6.5%5-Jahres-Durchschnitt ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 5.5%5-Jahres-Durchschnitt ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 3.4% | · | · | · | |
| EPS YoY (EPS VjV) | -8.3%5-Jahres-Durchschnitt ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -20.2%5-Jahres-Durchschnitt ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 18.9%5-Jahres-Durchschnitt ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 9.3% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 10.0%5-Jahres-Durchschnitt ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -0.70% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | DVA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.8 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 6.05-Jahres-Durchschnitt ≈6.0 | ≈6.0 | 10.6 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$174.9K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite0.00%
Ausschüttungsquote0.00%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.05%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 3, 2026 | $4.02 | $3.92 | 2.5% |
| 31. März 2026 | Mai 11, 2026 | $2.87 | $2.34 | 22.6% |
| 31. Dezember 2025 | $3.40 | $3.19 | 6.7% | |
| 30. September 2025 | $2.04 | $3.25 | -37.3% | |
| 30. Juni 2025 | $2.95 | $2.83 | 4.2% | |
| 31. März 2025 | $2.00 | $1.97 | 1.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Betriebsgewinnmarge % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Nettoergebnis | $747M | $936M | $692M | $560M | $978M |
| Verwässerte EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Institutionelle Eigentümer (13F) 692 Einreicher · $13.6B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
692
Gehaltener Wert
$13.6B
Neue Positionen
126
Geschlossene Positionen
61
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 126 (-14 vs. Vorquartal) | 61 (-2 vs. Vorquartal) | 195 (+23 vs. Vorquartal) | 226 (+12 vs. Vorquartal) | -1.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6.425.268.898 | 28.880.209 | 47,23% | Aktien |
| BlackRock, Inc. | $547.520.494 | 2.460.987 | 4,02% | Aktien |
| VANGUARD GROUP INC | $471.976.159 | 4.154.354 | 3,47% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $467.525.034 | 2.101.425 | 3,44% | Aktien |
| MORGAN STANLEY | $356.348.822 | 1.601.710 | 2,62% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306.558.307 | 1.377.914 | 2,25% | Aktien |
| STATE STREET CORP | $294.345.267 | 1.323.019 | 2,16% | Aktien |
| Invesco Ltd. | $269.627.293 | 1.211.917 | 1,98% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $253.130.449 | 1.137.814 | 1,86% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $205.758.498 | 925.579 | 1,51% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197.802.963 | 889.082 | 1,45% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $189.562.167 | 853.602 | 1,39% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163.166.832 | 733.400 | 1,20% | Kaufoption |
| Gates Capital Management, Inc. | $153.096.497 | 688.136 | 1,13% | Aktien |
| BANK OF AMERICA CORP /DE/ | $145.056.737 | 651.999 | 1,07% | Aktien |
| D. E. Shaw & Co., Inc. | $142.571.191 | 640.827 | 1,05% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $128.131.338 | 587.758 | 0,94% | Aktien |
| GOLDMAN SACHS GROUP INC | $103.093.004 | 463.381 | 0,76% | Aktien |
| Bank of New York Mellon Corp | $101.127.189 | 454.545 | 0,74% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $87.427.043 | 395.687 | 0,64% | Aktien |
| NORTHERN TRUST CORP | $84.995.593 | 382.037 | 0,62% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81.331.791 | 365.569 | 0,60% | Aktien |
| NORGES BANK | $76.627.007 | 344.422 | 0,56% | Aktien |
| UBS Group AG | $67.900.673 | 305.199 | 0,50% | Aktien |
| JANE STREET GROUP, LLC | $62.548.028 | 281.140 | 0,46% | Aktien |
| JANE STREET GROUP, LLC | $53.573.184 | 240.800 | 0,39% | Kaufoption |
| Holocene Advisors, LP | $52.875.709 | 237.665 | 0,39% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.100.176 | 216.200 | 0,35% | Verkaufsoption |
| ROYAL BANK OF CANADA | $47.787.000 | 214.787 | 0,35% | Aktien |
| DEUTSCHE BANK AG\ | $46.356.378 | 208.362 | 0,34% | Aktien |
| Quantinno Capital Management LP | $45.366.106 | 203.910 | 0,33% | Aktien |
| JPMORGAN CHASE & CO | $44.467.785 | 200.781 | 0,33% | Aktien |
| CITADEL ADVISORS LLC | $44.465.298 | 199.862 | 0,33% | Aktien |
| CITADEL ADVISORS LLC | $44.184.528 | 198.600 | 0,32% | Kaufoption |
| BARCLAYS PLC | $43.410.740 | 195.122 | 0,32% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $40.134.502 | 180.396 | 0,30% | Aktien |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37.089.700 | 241.328 | 0,27% | Aktien |
| Gotham Asset Management, LLC | $36.393.278 | 163.580 | 0,27% | Aktien |
| JANE STREET GROUP, LLC | $35.774.784 | 160.800 | 0,26% | Verkaufsoption |
| Doma Perpetual Capital Management LLC | $35.522.937 | 159.668 | 0,26% | Aktien |
| FIRST TRUST ADVISORS LP | $34.161.205 | 153.548 | 0,25% | Aktien |
| TODD ASSET MANAGEMENT LLC | $32.697.663 | 146.969 | 0,24% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32.011.312 | 143.884 | 0,24% | Aktien |
| Allianz Asset Management GmbH | $30.236.367 | 135.906 | 0,22% | Aktien |
| Toroso Investments, LLC | $29.297.520 | 257.878 | 0,22% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $26.480.460 | 119.024 | 0,19% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $26.377.896 | 118.563 | 0,19% | Aktien |
| Amundi | $25.967.198 | 116.717 | 0,19% | Aktien |
| FMR LLC | $25.475.535 | 114.507 | 0,19% | Aktien |
| Davidson Kempner Capital Management LP | $25.162.043 | 113.098 | 0,18% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 Einreichungen | 13. Februar 2025 | 45,00% | Änderung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 59 Insider · 31 Führungskräfte · 25 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16. Juni 2026 S | 840.408 | 0 | 2 | $-14.532.097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17. Mai 2016 S | 18.766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7. Mai 2026 S | 132.434 | 0 | 1 | $-9.887.579 |
| Luis Borgen | Chief Financial Officer | 22. März 2012 M | 18.517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31. März 2010 A | 33.604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14. März 2007 A | 31.250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1. Juli 2006 A | 10.000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 22. September 2026 F | 86.604 | 0 | 2 | $-4.089.696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16. August 2024 S | 209.365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24. Dezember 2016 A | 4.688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15. Juni 2026 S | 109.194 | 0 | 2 | $-3.210.360 |
| James O Hearty | Chief Compliance Officer | 14. Mai 2026 M | 22.389 | 0 | 2 | $-3.291.616 |
| Christopher Michael Berry | Chief Accounting Officer | 15. März 2026 A | 19.640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15. März 2023 F | 15.676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18. September 2020 M | 24.590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1. Juni 2020 F | 110.462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2. Juni 2019 F | 33.125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13. Juni 2017 M | 3.514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22. September 2015 M | 7.438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4. Juni 2015 S | 2.322.928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13. Februar 2014 M | 8.990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9. September 2013 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2. August 2013 G | 2.315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29. Februar 2012 M | 17.491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17. Juni 2009 M | 5.547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13. Februar 2009 M | 2.084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11. August 2008 M | 2.500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5. März 2008 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16. Juli 2007 A | 6.250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8. Mai 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4. November 2005 M | 42.000 | 0 | 0 | $0 |
| Dennis W Pullin | Direktor | 15. August 2026 A | 2.949 | 0 | 0 | $0 |
| Gregory J. Moore | Direktor | 15. August 2026 A | 8.091 | 0 | 0 | $0 |
| Jason M. Hollar | Direktor | 15. August 2026 A | 6.883 | 0 | 0 | $0 |
| Patricia M Arway | Direktor | 15. August 2026 A | 27.223 | 0 | 0 | $0 |
| Adam H Schechter | Direktor | 15. August 2026 A | 5.970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Direktor | 15. August 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Direktor | 15. August 2026 A | 9.803 | 0 | 0 | $0 |
| Barbara J Desoer | Direktor | 15. August 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Direktor | 15. Mai 2025 A | 19.982 | 0 | 0 | $0 |
| John M Nehra | Direktor | 15. Mai 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Direktor | 15. Mai 2023 A | 16.069 | 0 | 0 | $0 |
| Paula A Price | Direktor | 15. Mai 2022 A | 1.395 | 0 | 0 | $0 |
| Shawn M Guertin | Direktor | 15. Mai 2021 A | 1.105 | 0 | 0 | $0 |
| Pascal Desroches | Direktor | 15. November 2020 A | 8.030 | 0 | 0 | $0 |
| William L Roper | Direktor | 11. Juni 2020 A | 16.234 | 0 | 0 | $0 |
| Peter T Grauer | Direktor | 11. Juni 2020 A | 76.204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Direktor | 31. Dezember 2017 A | 10.764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Direktor | 11. Juni 2012 A | 7.195 | 0 | 0 | $0 |
| Richard C Vaughan | Direktor | 13. Mai 2010 A | 6.092 | 0 | 0 | $0 |
| Nancy Ann Deparle | Direktor | 30. Juni 2008 A | 3.256 | 0 | 0 | $0 |
| Raymond C Larkin JR | Direktor | 31. März 2007 A | 8.684 | 0 | 0 | $0 |
| Michele J Hooper | Direktor | 13. Mai 2005 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | 17. September 2020 S | 1.991.806 | 0 | 0 | $0 |
| Roger Valine | · | 30. Juni 2017 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | 17. Dezember 2015 M | 8.447 | 0 | 0 | $0 |
| Richard B Fontaine | · | 16. Mai 2007 G | 10.000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | 25. Februar 2005 M | 3.000 | 0 | 0 | $0 |
| Patrick A Broderick | · | 5. Mai 2004 M | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 97 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5,19% | 213.947 NS | 31. Juli 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 3,36% | 13.006 NS | 31. Juli 2026 | N-PORT |
| AZTD · Tidal Trust I | 3,06% | 4.824 NS | 31. Juli 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,44% | 106.663 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,61% | 78.824 SH | 5. Oktober 2026 | Täglich |
| AMOM · Exchange Listed Funds Trust | 1,41% | 1.399 NS | 31. Juli 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,19% | 760 NS | 31. Juli 2026 | N-PORT |
| IHF · iShares Trust | 0,85% | 61.700 SH | 11. September 2026 | Täglich |
| JMID · Janus Detroit Street Trust | 0,46% | 456 NS | 31. Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,46% | 8.917 NS | 31. Juli 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,34% | 4.688 NS | 31. Juli 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 6.488 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9.914 SH | 19. August 2026 | Täglich |
| ROSC · Lattice Strategies Trust | 0,27% | 691 NS | 31. Juli 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22.494 SH | 5. Oktober 2026 | Täglich |
| BKMC · BNY Mellon ETF Trust | 0,22% | 5.948 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,20% | 126.925 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1.063.098 SH | 5. Oktober 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 15.260 NS | 31. Juli 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 1.456 NS | 31. Juli 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467.367 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 15.871 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 6.102 SH | 11. September 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,11% | 100.394 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,10% | 16.178 SH | 11. September 2026 | Täglich |
| IYH · iShares Trust | 0,09% | 18.805 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 4.169 SH | 5. Oktober 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736.199 SH | 19. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,09% | 632 NS | 31. Juli 2026 | N-PORT |
| SMMD · iShares Trust | 0,08% | 17.274 SH | 11. September 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 4.629 NS | 31. Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 7.288 NS | 31. Juli 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16.934 SH | 11. September 2026 | Täglich |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 38.208 SH | 5. Oktober 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,06% | 121.442 NS | 31. Juli 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3.250 SH | 5. Oktober 2026 | Täglich |
| DUHP · Dimensional ETF Trust | 0,06% | 29.605 NS | 31. Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2.005 SH | 10. September 2026 | Täglich |
| IWS · iShares Trust | 0,05% | 45.297 SH | 11. September 2026 | Täglich |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,05% | 322 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,04% | 131.978 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,04% | 5.974 NS | 31. Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 1.967 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,04% | 43 SH | 10. September 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15.588 SH | 5. Oktober 2026 | Täglich |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,03% | 34.484 SH | 5. Oktober 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,03% | 13.203 NS | 31. Juli 2026 | N-PORT |
| CHRI · Global X Funds | 0,02% | 8 NS | 31. Juli 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2.124 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,02% | 2 NS | 31. Juli 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,02% | 7.420 SH | 19. August 2026 | Täglich |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 18.428 SH | 19. August 2026 | Täglich |
| IVE · iShares Trust | 0,02% | 53.283 SH | 11. September 2026 | Täglich |
| IUSV · iShares Trust | 0,02% | 27.948 SH | 11. September 2026 | Täglich |
| NEAR · iShares U.S. ETF Trust | 0,02% | 949.000 SH | 9. September 2026 | Täglich |
| DSI · iShares Trust | 0,02% | 4.810 SH | 11. September 2026 | Täglich |
| IWD · iShares Trust | 0,01% | 67.699 SH | 11. September 2026 | Täglich |
| XRMI · Global X Funds | 0,01% | 30 NS | 31. Juli 2026 | N-PORT |
| XYLD · Global X Funds | 0,01% | 1.746 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 1.706 NS | 31. Juli 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 27.844 SH | 11. September 2026 | Täglich |
| XYLG · Global X Funds | 0,01% | 32 NS | 31. Juli 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 121 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 9.492 NS | 31. Juli 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,01% | 766 NS | 31. Juli 2026 | N-PORT |
| TOPC · iShares Trust | 0,01% | 19 SH | 10. September 2026 | Täglich |
| XVV · iShares Trust | 0,01% | 377 SH | 10. September 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 832.243 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1.019.458 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 28.136 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.315 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 2.714 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7.283 SH | 19. August 2026 | Täglich |
| XTR · Global X Funds | 0,01% | 2 NS | 31. Juli 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,01% | 225 NS | 31. Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 203 SH | 5. Oktober 2026 | Täglich |
| IWP · iShares Trust | 0,01% | 9.703 SH | 11. September 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,01% | 2.512 NS | 31. Juli 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 404.382 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,01% | 22.249 SH | 11. September 2026 | Täglich |
| IYY · iShares Trust | 0,01% | 1.374 SH | 10. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 8.841 SH | 10. September 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 41.624 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 24 SH | 5. Oktober 2026 | Täglich |
| XCLR · Global X Funds | 0,01% | 1 NS | 31. Juli 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1.542 SH | 2. Oktober 2026 | Täglich |
| IWF · iShares Trust | 0,00% | 6.443 SH | 2. September 2026 | Täglich |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 7.000 | 30. September 2026 | Täglich |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.838 SH | 19. August 2026 | Täglich |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15. Juli 2026 | Täglich |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| ISCB · iShares Trust | · | 1.571 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 3.661 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 5.973 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 1.837 SH | 1. September 2026 | Täglich |
DVA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$220.00
+22,0%
1 7,7%
Starker Kauf
6 46,2%
Kauf
5 38,5%
Halten
1 7,7%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
7 Analysten · 2026-10-04Mittelwert-Ziel $219.86 +21,9%
Jetzt
Aktueller Preis $180.40
Tief$165.00
Mittelwert$219.86
Hoch$270.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
BLUECHIP_DIP
Stop-Loss ausgelöst
Risiko 1
Belohnung 2,08
Einstieg
$179.50
R:R 2,08
BLUECHIP_DIP
Abgelaufen
Risiko 1
Belohnung 2,08
Einstieg
$176.69
R:R 2,08
Derzeit kein offenes Signal – keine Karte ist ausgefüllt, und das ist ehrlich.
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026